Congressional Record publishes “Cloture Motion (Executive Session)” in the Senate section on Feb. 10

0Comments

Christopher A. Coons and Thomas R. Carper were mentioned in Cloture Motion (Executive Session) on page S621 covering the 2nd Session of the 117th Congress published on Feb. 10 in the Congressional Record.

The publication is reproduced in full below:

Cloture Motion

Mr. SCHUMER. Madam President, I send a cloture motion to the desk.

The ACTING PRESIDENT pro tempore. The cloture motion having been presented under rule XXII, the Chair directs the clerk to read the motion.

The senior assistant legislative clerk read as follows:

Cloture Motion

We, the undersigned Senators, in accordance with the provisions of rule XXII of the Standing Rules of the Senate, do hereby move to bring to a close debate on the nomination of Executive Calendar No. 668, Robert McKinnon Califf, of North Carolina, to be Commissioner of Food and Drugs, Department of Health and Human Services.

Charles E. Schumer, Patty Murray, Richard Blumenthal,

Gary C. Peters, Robert P. Casey, Jr., Sheldon

Whitehouse, Martin Heinrich, Richard J. Durbin, Sherrod

Brown, Tammy Duckworth, Tim Kaine, Mazie K. Hirono,

Alex Padilla, Tina Smith, Christopher A. Coons, Amy

Klobuchar, Jon Tester.

____________________

SOURCE: Congressional Record Vol. 168, No. 27

The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.

Senators’ salaries are historically higher than the median US income.



Related

John T. Dorsey Chief Judge at U.S. Bankruptcy Court for the District of Delaware

Judge John T. Dorsey remembered after passing following battle with cancer

Judge John T. Dorsey has passed away following a battle with cancer, according to an announcement from the U.S. Bankruptcy Court for the District of Delaware on Apr. 15. He served as Chief Judge from 2024-2025 and had a long career dedicated to public service.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA inspection: Which types of Delaware companies faced the most scrutiny in March?

The U.S. Food and Drug Administration (FDA) carried out inspections at two food and cosmetics companies in Delaware during March.

Benjamin D. Moncarz Chief Financial Officer - FDA

Device companies saw the fewest FDA inspections in Delaware in 2025

The U.S. Food and Drug Administration (FDA) carried out an inspection at a device manufacturer in Delaware in 2025.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.